一种基于胰岛素的葡萄糖片,用于针对病原体的药物输送,以改善沙门氏菌病
Yujie Xu1, Congmin Niu2, Shuyi Liang2
1College of Chemistry & Pharmacy, Shaanxi Key Laboratory of Natural Products & Chemical Biology, Northwest A&F University, Yangling 712100, Shaanxi, China.
International journal of biological macromolecules
|April 18, 2024
概括
传递levofloxacin和inulin的新型纳米细胞显示出治疗炎症性肠病的前景. 这些向的菌体对抗病原体并恢复肠道细菌,与传统抗生素相比,它们具有更好的治疗效果.
科学领域:
- 胃肠病学 胃肠病学
- 微生物学 微生物学
- 纳米技术 纳米技术
背景情况:
- 炎症性肠病 (IBD) 的发病和缓解与肠道微生物群组成有关.
- 传统的抗生素可以破坏肠道微生物群,导致失生症和治疗效率降低.
- 开发有针对性的疗法对于有效的IBD治疗至关重要.
研究的目的:
- 开发新的H2S响应的纳米细胞,将胰岛素与勒沃素结合起来,以进行向的输送.
- 评估这些纳米细胞在治疗沙门氏病和改善体内炎症方面的疗效.
- 评估胰岛素对肠道微生物群平衡的益生菌作用.
主要方法:
- 合成与二硫化物结合的纳米细胞,封装胰岛素和levofloxacin.
- 在沙门氏病小鼠模型中的体内评估.
- 评估细菌负载,肠道屏障功能和炎症标志物.
主要成果:
- 这些纳米细胞选择性地向炎症的结肠组织.
- 利沃弗洛克萨辛的释放速度很快,并且具有病原体特异性.
- 胰岛素补充剂增加了有益的Bifidobacteria和乳酸菌.
- 多功能纳米细胞表现出优越的抗炎作用,相比于自由的levofloxacin.
结论:
- 针对病原体的糖囊是IBD治疗的有前途的药物输送平台.
- 这种方法可以提高抗菌效果,同时调节肠道微生物群.
- 开发的纳米细胞为改善IBD管理提供了潜在的策略.
相关概念视频
Drug Delivery: Enteral Route
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
Drugs in...
Drugs in...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


